Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ANTARES PHARMA, INC. | Director | Common Stock | 0 | $5.60 | May 24, 2022 | Direct | |
ANTARES PHARMA, INC. | Director | Stock Option (right to buy) | 0 | May 24, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATRS | ANTARES PHARMA, INC. | May 24, 2022 | 10 | -$955K | 4 | May 26, 2022 | Director |
ATRS | ANTARES PHARMA, INC. | Dec 31, 2021 | 1 | $0 | 5 | Feb 4, 2022 | Director |
ATRS | ANTARES PHARMA, INC. | Aug 27, 2021 | 3 | $0.96 | 4 | Aug 31, 2021 | Director |
ATRS | ANTARES PHARMA, INC. | Jun 10, 2021 | 2 | $140K | 4 | Jun 14, 2021 | Director |